Literature DB >> 10385669

Acute sporadic non-A, non-B hepatitis in Northeastern Brazil: etiology and natural history.

R Paraná1, L Vitvitski, Z Andrade, C Trepo, H Cotrim, P Bertillon, F Silva, L Silva, I R de Oliveira, L Lyra.   

Abstract

In a 4-year follow-up study, patients with acute sporadic non-A, non-B (NANB) hepatitis were evaluated to determine the etiology and natural history of the disease. Acute hepatitis C virus (HCV) was detected in 13 of 43 (30%) of patients, anti-hepatitis E virus (HEV) IgG in 5 (12%), and 25 (58%) were considered non-A-E. The HCV RNA was detected in all HCV patients but none of the non-A-E cases. The initial clinical and biochemical presentation of the HCV and non-A-E cases was quite similar, although 2 of the non-A-E patients had severe disease. The 5 patients who were found to be anti-HEV IgG-reactive recovered within 6 months of follow-up. Of the 13 HCV cases, alanine transaminase (ALT) levels returned to normal in 7 (53. 8%), while 6 (46.2%) continued to show abnormal ALT after 6 months of follow-up. However, 9 (69.2%) of them remained HCV-RNA-positive, denoting virological/biochemical dissociation. Long-term follow-up showed a reappearance of HCV RNA in 2 of the 4 patients who were in virological remission performing 84% of chronicity rate. Acute non-A-E hepatitis patients were less likely to evolve toward chronicity, as compared with acute HCV cases (16% vs. 84%; P =.0001). Only 4 (16%) of the non-A-E patients were hepatitis G virus (HGV)-RNA-positive. Concerning risk factors for acquiring parenterally transmitted viruses, tattooing was the only one that could be associated with HCV transmission (P =.002). No risk factors could be identified for putative non-A-E virus transmission. Liver biopsies performed for chronic HCV patients showed a variable degree of inflammation, while the non-A-E patients presented less severe histological disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385669     DOI: 10.1002/hep.510300143

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Hepatitis E virus immunoglobulin G antibodies in different populations in Campinas, Brazil.

Authors:  N S Gonçales; J R Pinho; R C Moreira; C P Saraceni; A M Spina; R B Stucchi; A D Filho; L A Magna; F L Gonçales Júnior
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

2.  Tattooing and transfusion-transmitted diseases in Brazil: a hospital-based cross-sectional matched study.

Authors:  Sérgio A de Nishioka; T W Gyorkos; L Joseph; J P Collet; J D MacLean
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

3.  Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study.

Authors:  Hirofumi Uto; Sherri O Stuver; Katsuhiro Hayashi; Kotaro Kumagai; Fumisato Sasaki; Shuji Kanmura; Masatsugu Numata; Akihiro Moriuchi; Susumu Hasegawa; Makoto Oketani; Akio Ido; Kazunori Kusumoto; Satoru Hasuike; Kenji Nagata; Michinori Kohara; Hirohito Tsubouchi
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

Review 4.  Hepatitis G virus.

Authors:  Vasiliy Ivanovich Reshetnyak; Tatiana Igorevna Karlovich; Ljudmila Urievna Ilchenko
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

5.  Cross-sectional study to determine viral hepatitis knowledge in different urban populations in Brazil.

Authors:  Helena Medina Cruz; Jakeline Ribeiro Barbosa; Jeová Keny Baima Colares; Antonio Henrique Almeida de Moraes Neto; Maria de Fátima Leal Alencar; Francisco Inácio Bastos; Jurema Corrêa da Mota; Filipe Aníbal Carvalho-Costa; Claudia Alexandra Pontes Ivantes; Lia Laura Lewis-Ximenez; Livia Melo Villar
Journal:  World J Hepatol       Date:  2018-11-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.